| Margot O'donnell, MD | |
|
1062 E Lancaster Ave, Suite 23a, Bryn Mawr, PA 19010-1552 | |
| (215) 621-6201 | |
| Not Available |
| Full Name | Margot O'donnell |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1062 E Lancaster Ave, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083770507 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MT188208 (Pennsylvania) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD435321 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Margot O'donnell, MD 1062 E Lancaster Ave, Suite 23a, Bryn Mawr, PA 19010-1552 Ph: (215) 621-6201 | Margot O'donnell, MD 1062 E Lancaster Ave, Suite 23a, Bryn Mawr, PA 19010-1552 Ph: (215) 621-6201 |
News Archive
A landmark study to be published in the October 30, 2014 print edition of the journal Nature provides new insight into the function of an enzyme related to the BRCA1 breast-cancer protein. The study by a team at Penn State University is the first to produce a detailed working image of an enzyme in the Polycomb Repressive Complex 1 (PRC1) - a group that regulates cell development and is associated with many types of cancer.
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.
Researchers have developed a risk calculator to provide personalized risk estimates of developing kidney failure after donation.
Peritoneal carcinomatosis can be thought of as a series of events that together form a peritoneal metastatic cascade.
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
› Verified 7 days ago
Dr. John W Dougherty Iii, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 937 E Haverford Rd, Suite 100, Bryn Mawr, PA 19010 Phone: 888-566-8774 | |
Elizabeth S Goldman, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1062 E Lancaster Ave, Suite 6, Bryn Mawr, PA 19010 Phone: 610-527-5927 Fax: 267-708-0790 | |
Dr. Christina Lee Herring, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1030 E Lancaster Ave Apt L6, Bryn Mawr, PA 19010 Phone: 610-525-1113 Fax: 610-525-2498 | |
Dr. Susan Poritsky, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 940 E Haverford Rd Ste 202, Bryn Mawr, PA 19010 Phone: 610-525-0390 Fax: 610-884-5160 | |
Marjorie Somers, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1062 E Lancaster Ave, Suite One, Bryn Mawr, PA 19010 Phone: 610-246-2990 | |
Dr. Arnold Feldman, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 14 Elliott Ave, Suite B, Bryn Mawr, PA 19010 Phone: 610-527-8874 |